Carla Cano

R&D Lead Discovery Director at Imcheck Therapeutics

Speaker

Carla Cano is the Lead Discovery Director at ImCheck Therapeutics, a clinical-stage biotech pioneering innovative therapies that harness butyrophilins and γδT cells to combat cancer and infectious diseases. In this role, she leads the Concept Design Team, driving innovative approaches that advance ImCheck's early-stage pipeline. With a robust background in immunology, Carla has contributed significantly to research in oncology, cellular stress, and HIV/Hepatitis. She earned her PhD in Immunology from Aix-Marseille University at the Centre d’Immunologie de Marseille-Luminy (CIML), followed by a Postdoctoral Fellowship and a Confirmed Young Scientist Fellowship at the Cancer Research Center of Marseille (CRCM).